MedPath

Jace Pharma Pty Ltd.

🇦🇺Australia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

TGA:2

Drug Approvals

CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets (337139)

Product Name
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets
Approval Date
Sep 28, 2021
TGA

OXERVATE cenegermin (rbe) 20 micrograms/mL eye drops, solution vials (310960)

Product Name
OXERVATE cenegermin (rbe) 20 micrograms/mL eye drops, solution vials
Approval Date
Sep 30, 2019
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.